Secondary efficacy results from a phase 3 study comparing efficacy and safety of biosimilar candidate ABP 215 with bevacizumab in patients with non-squamous non-small cell lung cancer (NSCLC)

N. Thatcher; M. Thomas; G. Ostoros; J. Pan; J. Goldschmidt; V. Hanes

doi:10.1093/ANNONC/MDW382.10

Secondary efficacy results from a phase 3 study comparing efficacy and safety of biosimilar candidate ABP 215 with bevacizumab in patients with non-squamous non-small cell lung cancer (NSCLC)

N. Thatcher
, M. Thomas
, G. Ostoros
, J. Pan
, J. Goldschmidt
, V. Hanes

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Annals of Oncology
Volume	27
DOIs	https://doi.org/10.1093/ANNONC/MDW382.10
State	Published - Oct 1 2016

Disciplines

Pharmacology
Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1093/ANNONC/MDW382.10License: Unspecified

Cite this

@article{96b306649dde4659bad12eaabc1054bb,

title = "Secondary efficacy results from a phase 3 study comparing efficacy and safety of biosimilar candidate ABP 215 with bevacizumab in patients with non-squamous non-small cell lung cancer (NSCLC)",

author = "N. Thatcher and M. Thomas and G. Ostoros and J. Pan and J. Goldschmidt and V. Hanes",

note = "Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines † Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group Visibility.",

year = "2016",

month = oct,

day = "1",

doi = "10.1093/ANNONC/MDW382.10",

language = "American English",

volume = "27",

journal = "Annals of Oncology",

issn = "1569-8041",

publisher = "Elsevier",

}

TY - JOUR

T1 - Secondary efficacy results from a phase 3 study comparing efficacy and safety of biosimilar candidate ABP 215 with bevacizumab in patients with non-squamous non-small cell lung cancer (NSCLC)

AU - Thatcher, N.

AU - Thomas, M.

AU - Ostoros, G.

AU - Pan, J.

AU - Goldschmidt, J.

AU - Hanes, V.

N1 - Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines † Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group Visibility.

PY - 2016/10/1

Y1 - 2016/10/1

UR - https://academic.oup.com/annonc/article/27/suppl_6/1196P/2800055

U2 - 10.1093/ANNONC/MDW382.10

DO - 10.1093/ANNONC/MDW382.10

M3 - Article

SN - 1569-8041

VL - 27

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Secondary efficacy results from a phase 3 study comparing efficacy and safety of biosimilar candidate ABP 215 with bevacizumab in patients with non-squamous non-small cell lung cancer (NSCLC)

Disciplines

Access to Document

Other files and links

Cite this